DREVZO Trademark

Trademark Overview

On Tuesday, June 2, 2020, a trademark application was filed for DREVZO with the United States Patent and Trademark Office. The USPTO has given the DREVZO trademark a serial number of 88943916. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 19, 2023. This trademark is owned by Johnson & Johnson. The DREVZO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment of autoimmune diseases and disorders
drevzo

General Information

Serial Number88943916
Word MarkDREVZO
Filing DateTuesday, June 2, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment of autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 23, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Tuesday, June 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 19, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, November 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2022SOU EXTENSION 4 GRANTED
Monday, November 7, 2022SOU EXTENSION 4 FILED
Monday, November 7, 2022TEAS EXTENSION RECEIVED
Friday, April 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 20, 2022SOU EXTENSION 3 FILED
Wednesday, April 20, 2022TEAS EXTENSION RECEIVED
Wednesday, November 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 15, 2021SOU EXTENSION 2 GRANTED
Monday, November 15, 2021SOU EXTENSION 2 FILED
Monday, November 15, 2021TEAS EXTENSION RECEIVED
Wednesday, April 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 26, 2021SOU EXTENSION 1 GRANTED
Monday, April 26, 2021SOU EXTENSION 1 FILED
Monday, April 26, 2021TEAS EXTENSION RECEIVED
Tuesday, November 17, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 18, 2020ASSIGNED TO EXAMINER
Tuesday, June 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 5, 2020NEW APPLICATION ENTERED

Related Keywords

drevzo diseases disorders autoimmune treatment preparations pharmaceutical